Tigermed
Qili Yu is a skilled professional with extensive experience in statistical analysis and scientific research. Currently serving as a Statistical Analyst at Tigermed since September 2021 and simultaneously working as a Scientist at Visikol Inc since February 2020, Qili Yu has demonstrated a strong ability to integrate analytical skills with scientific inquiry. Prior experience includes a role as a Postdoctoral Fellow at the Child Health Institute of New Jersey from February 2018 to January 2020 and a PhD student at Rutgers University from September 2010 to December 2017, where Qili Yu earned a Doctor of Philosophy in Neuroscience.
This person is not in any offices
Tigermed
1 followers
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees across 50 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibilities for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.